XOMA (NASDAQ:XOMAO – Get Free Report) is expected to be releasing its resultson Thursday, July 30th. Analysts expect the company to announce earnings of $0.1761 per share and revenue of $13.91 million for the quarter.
XOMA Price Performance
Shares of XOMAO opened at $25.00 on Thursday. XOMA has a one year low of $24.86 and a one year high of $26.40. The business’s 50 day simple moving average is $25.26 and its 200-day simple moving average is $25.36.
XOMA Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, July 14th. Shareholders of record on Thursday, July 2nd were given a $0.5234 dividend. The ex-dividend date was Thursday, July 2nd. This represents a $2.09 annualized dividend and a yield of 8.4%.
XOMA Company Profile
XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early‐stage clinical development.
In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.
Featured Articles
- Five stocks we like better than XOMA
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
